{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:51:32Z","timestamp":1761061892661,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2021J011379"],"award-info":[{"award-number":["2021J011379"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jpba.2023.115900","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T21:08:58Z","timestamp":1701551338000},"page":"115900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Metabolomic analysis identifies dysregulation of lipid metabolism in the immune clearance phase of chronic hepatitis B patients"],"prefix":"10.1016","volume":"239","author":[{"given":"Xiangyang","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbing","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10381","key":"10.1016\/j.jpba.2023.115900_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jpba.2023.115900_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2023.115900_bib3","unstructured":"European Association for the Study of the Liver. Electronic address, e.e.e. and L. European Association for the Study of the, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol, 2017. 67(2): p. 370\u2013398."},{"issue":"1","key":"10.1016\/j.jpba.2023.115900_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep4.1281","article-title":"Hepatitis B treatment: what we know now and what remains to be researched","volume":"3","author":"Suk-Fong Lok","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"3","key":"10.1016\/j.jpba.2023.115900_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.1840080310","article-title":"The development of cirrhosis in patients with chronic type B hepatitis: a prospective study","volume":"8","author":"Liaw","year":"1988","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jpba.2023.115900_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jpba.2023.115900_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12020194","article-title":"The potential of metabolomics in biomedical applications","volume":"12","author":"Gonzalez-Covarrubias","year":"2022","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.jpba.2023.115900_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/10408347.2020.1842172","article-title":"Application of metabolomics in diagnosis and treatment of chronic liver diseases","volume":"52","author":"Tang","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jpba.2023.115900_bib9","doi-asserted-by":"crossref","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","article-title":"Metabolomics in viral hepatitis: advances and review","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"issue":"5","key":"10.1016\/j.jpba.2023.115900_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156166","article-title":"Covariation analysis of serumal and urinary metabolites suggests aberrant glycine and fatty acid metabolism in chronic hepatitis B","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jpba.2023.115900_bib11","first-page":"888","article-title":"The guideline of prevention and treatment for chronic hepatitis B: a 2015 update","volume":"23","author":"Chinese Society of Hepatology","year":"2015","journal-title":"Zhonghua Gan Zang Bing. Za Zhi"},{"issue":"2","key":"10.1016\/j.jpba.2023.115900_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-020-01767-y","article-title":"Metabolic fingerprint of progression of chronic hepatitis B: changes in the metabolome and novel diagnostic possibilities","volume":"17","author":"Nguyen","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2023.115900_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgad067","article-title":"Metabolomic analysis identifies the regulation of lipid metabolism pathway as potential mechanisms of Jiangzhi decoction against non-alcoholic fatty liver disease","author":"Wang","year":"2023","journal-title":"J. Pharm. Pharm."},{"issue":"2","key":"10.1016\/j.jpba.2023.115900_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acsomega.0c04259","article-title":"LC\/MS-based global metabolomic identification of serum biomarkers differentiating hepatocellular carcinoma from chronic hepatitis b and liver cirrhosis","volume":"6","author":"Pan","year":"2021","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.jpba.2023.115900_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","article-title":"Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury","volume":"142","author":"Moustafa","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jpba.2023.115900_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000187","article-title":"Dysregulation of lipid metabolism in the pseudolobule promotes region-specific autophagy in hepatitis B liver cirrhosis","volume":"7","author":"Pu","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jpba.2023.115900_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2018.12.006","article-title":"Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review","volume":"17","author":"Das","year":"2019","journal-title":"J. Adv. Res"},{"issue":"4\u20136","key":"10.1016\/j.jpba.2023.115900_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.plefa.2010.02.012","article-title":"Fatty liver: role of inflammation and fatty acid nutrition","volume":"82","author":"Byrne","year":"2010","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"11","key":"10.1016\/j.jpba.2023.115900_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00109-021-02117-8","article-title":"Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1","volume":"99","author":"Cheon","year":"2021","journal-title":"J. Mol. Med (Berl. )"},{"key":"10.1016\/j.jpba.2023.115900_bib20","article-title":"Therapeutic effects of berberine on liver fibrosis are associated with lipid metabolism and intestinal flora","volume":"13","author":"Liu","year":"2022","journal-title":"Front Pharm."},{"issue":"24","key":"10.1016\/j.jpba.2023.115900_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246333","article-title":"Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease","volume":"20","author":"Gaggini","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.jpba.2023.115900_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176358","article-title":"Novel insights and mechanisms of lipotoxicity-driven insulin resistance","volume":"21","author":"Lair","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jpba.2023.115900_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jpba.2023.115900_bib24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","article-title":"Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans","volume":"278","author":"Wanders","year":"2011","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.jpba.2023.115900_bib25","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jpba.2023.115900_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100108","article-title":"Distinct biological activities of isomers from several families of branched fatty acid esters of hydroxy fatty acids (FAHFAs)","volume":"62","author":"Aryal","year":"2021","journal-title":"J. Lipid Res"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:31:37Z","timestamp":1760002297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523006696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":26,"alternative-id":["S0731708523006696"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115900","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic analysis identifies dysregulation of lipid metabolism in the immune clearance phase of chronic hepatitis B patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115900"}}